HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of prostacyclin in the treatment of patients with chronic occlusion of the peripheral arteries (stage IV)].

Abstract
Preliminary results of the use of prostacyclin in 6 patients with peripheral arterial occlusive disease (IV stage) are presented. Diagnosis was supported by clinical signs, Doppler ultrasound and arteriography. There were 4 diabetics, one with Mb Bürger and the other with obliterant atherosclerosis. All patients were unsuccessful by treated with antiaggregants, vasodilators and haemorheological medicaments. The reconstructive vascular surgery was also impossible. However amputation was necessary. The patients treated by intra-venous and intra-arterial prostacyclin administration in the dose of 5 ng/kg b.w./min during different periods of time (24, 48, 72 h). During intrahospital treatment complete relief of pain and gangrene demarcation in all patients. One month later two patients manifested necrotic progression and amputation of a limb was necessary. The long-term clinical success was registered in 4 patients (1-16) months). Indications, doses, side effects of prostacyclin action are discussed.
AuthorsZ Maksimović, V Djukić, S Lotina, V Mujović, Dj Radak
JournalSrpski arhiv za celokupno lekarstvo (Srp Arh Celok Lek) 1989 Jan-Feb Vol. 117 Issue 1-2 Pg. 17-25 ISSN: 0370-8179 [Print] Serbia
Vernacular TitlePrimena prostaciklina u lecenju bolesnika sa hronicnom okluzijom perifernih arterija (IV stadium).
PMID2508243 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Epoprostenol
Topics
  • Adult
  • Aged
  • Arterial Occlusive Diseases (drug therapy, pathology)
  • Chronic Disease
  • Epoprostenol (adverse effects, therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: